Cite
HARVARD Citation
Siskind, E. et al. (2019). Use of Mammalian Target of Rapamycin Inhibitors for Pancreas Transplant Immunosuppression Is Associated With Improved Allograft Survival and Improved Early Patient Survival. Pancreas. 48 (5), p. . [Online].